Effect of 8-weeks intensive lifestyle intervention on LDL and HDL subfractions

Obes Res Clin Pract. 2019 Nov-Dec;13(6):586-593. doi: 10.1016/j.orcp.2019.10.010. Epub 2019 Dec 2.

Abstract

Objective: Atherogenic dyslipidemia is a cardinal feature of obesity and the metabolic syndrome, which increases the risk of cardiovascular diseases. Many interventional studies, describing the influence of weight loss on cardiometabolic risks, are bariatric surgery studies. The aim of our study was to analyze the effect of intensive lifestyle changes on LDL- and HDL-cholesterol subfractions and cardiometabolic risk factors in obese subjects.

Methods: A group of 41 patients with obesity (11M/30F; 44.1±12.4 years; BMI 30.2±6.3kg/m2) participated in an 8-week weight loss interventional program (NCT02325804), consisting of caloric intake reduced by 30% and physical activity (150min/week). Insulin sensitivity was evaluated according to the homeostasis model assessment of insulin resistance (HOMA-IR) and physical fitness was measured using bicycle ergometry. Lipid subfractions were measured using the Lipoprint system (Quantimetrix Corp., CA, USA).

Results: After the intervention, body weight was reduced by 5.4±4.5kg, as well as body fat mass and waist circumference. Physical fitness improved, systolic and diastolic blood pressure as well as heart rate decreased after the intervention. Insulin sensitivity improved after the intervention. Total, LDL, HDL cholesterol, as well as triglycerides decreased after the intervention. Regarding the lipoprotein subfractions, LDL2 and small HDL subfractions decreased, while others have not changed.

Conclusion: Eight weeks of diet and physical activity intervention led to weight and fat mass loss and induced improvement of insulin sensitivity, as well as atheroprotective changes of lipid profile. However, the weight loss associated changes in cholesterol subfractions as cardiovascular risk biomarkers deserve further studies.

Keywords: Abdominal obesity; Cholesterol; HDL and LDL lipoprotein subfractions; Insulin sensitivity; Weight loss.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cholesterol, HDL / blood*
  • Cholesterol, LDL / blood*
  • Dyslipidemias / blood*
  • Dyslipidemias / therapy*
  • Female
  • Humans
  • Life Style*
  • Longitudinal Studies
  • Male
  • Program Evaluation / methods*
  • Prospective Studies
  • Risk Factors

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL

Associated data

  • ClinicalTrials.gov/NCT02325804